Spectrum Pharmaceuticals

.

FDA OK’s Spectrum Cancer Drug for Wider Use

Spectrum Pharmaceuticals

An Irvine drug maker, Spectrum Pharmaceuticals Inc., has said that it got regulatory approval for an expanded use of a cancer drug.

Spectrum said that the FDA approved Zevalin as an early treatment for a blood cancer, in patients with non-Hodgkin's lymphoma. The drug was used previously on patients whose tumors did not respond to other treatments.

Spectrum Pharmaceuticals inks 50:50 JV pact with Cell Therapeutics

Spectrum Pharmaceuticals inks 50:50 JV pact with Cell Therapeutics Spectrum Pharmaceuticals and Cell Therapeutics have entered into an agreement to form a 50:50 owned joint venture, RIT Oncology, to commercialize and develop Zevalin in the United States.

Latest News

Amtrak will Keep Trains Running on the Kansas and Missouri Routes
Canadian Starbucks Stores will Raise Prices of Certain Drink by 10 to 20 cents S
Banks Submit Contingency Plan to Handle Crisis Situation Smoothly without Affect
Greek Prime Minister Expected to Present New Proposals at eurozone Summit
New Measures Introduced by China to Boost Economy Fail to Bring Long-lasting Con
Overwhelming ‘No’ vote by Greeks Make the Nation’s Future Uncertain
CPUC Votes Unanimously to Support a Revised Version of Electricity Pricing
It’s Quite Likely that Greek Bank Customers have to Bear More Financial Pain
JetBlue Starts Weekly Charter Flights to Havana from  New York
Californians Will Face Changes in Electricity Bill as PUC Gets Ready to Vote on
Increase in the Number of U.S. Oil Drilling Rigs Break the 29 Week Successive De
Though Employers Hire at Steady Rate Wages Remain Flat
Syndicate content